{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:36:50Z","timestamp":1768250210336,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jcrc.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T13:31:44Z","timestamp":1397827904000},"page":"803-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit"],"prefix":"10.1016","volume":"29","author":[{"given":"Caitlin M.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcrc.2014.04.005_bb0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/bja\/aeg275","article-title":"Constipation and its implications in the critically ill patient","volume":"91","author":"Mostafa","year":"2003","journal-title":"Brit J Anaesth"},{"issue":"14","key":"10.1016\/j.jcrc.2014.04.005_bb0010","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2165\/11634970-000000000-00000","article-title":"Opioid-induced bowel dysfunction","volume":"72","author":"Brock","year":"2012","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.jcrc.2014.04.005_bb0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/jpm.2007.0178","article-title":"A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer","volume":"11","author":"Hawley","year":"2008","journal-title":"J Palliat Med"},{"issue":"7","key":"10.1016\/j.jcrc.2014.04.005_bb0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1592\/phco.26.7.896","article-title":"Pharmacologic management of constipation in the critically ill patient","volume":"26","author":"Patanwala","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcrc.2014.04.005_bb0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-2036.2001.00970.x","article-title":"Effect of an enteric-release formulation of naloxone on intestinal transit in volunteers taking codeine","volume":"15","author":"Hawkes","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jcrc.2014.04.005_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1992.106","article-title":"Treatment of opioid-induced constipation with oral naloxone: a pilot study","volume":"52","author":"Culpepper","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jcrc.2014.04.005_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliat Med"},{"key":"10.1016\/j.jcrc.2014.04.005_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","article-title":"Oral naloxone reverses opioid-associated constipation","volume":"84","author":"Meissner","year":"2000","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.jcrc.2014.04.005_bb0045","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.jcrc.2014.04.005_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Wittbrodt: low-dose oral naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu","year":"2002","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jcrc.2014.04.005_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2710.2008.00982.x","article-title":"Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit","volume":"34","author":"Arpino","year":"2009","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.jcrc.2014.04.005_bb0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/01.CCM.0000053652.80849.9F","article-title":"Enteral naloxone reduces gastric tube reflux and frequency of pneumonia in critical care patients during opioid analgesia","volume":"31","author":"Meissner","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2014.04.005_bb0065","series-title":"Relistor (methylnaltrexone bromide)","article-title":"Product information","year":"2012"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944114001427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944114001427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T16:55:24Z","timestamp":1538672124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944114001427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0883944114001427"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2014.04.005","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}